BIOINCUBATION CORP
NT 10-Q, 2000-05-15
NON-OPERATING ESTABLISHMENTS
Previous: FIRST DEPOSIT BANCSHARES INC, 10QSB, 2000-05-15
Next: ANGELAUDIO COM INC /DE/, 10QSB, 2000-05-15



                          UNITED STATES
                  SECURITIES EXCHANGE COMMISSION
                      WASHINGTON, D.C. 20549

                           FORM 12b-25

                       BIOINCUBATION, INC.

            NOTIFICATION OF LATE FILING OF FORM 10-Q


For the Period Ended: March 30, 2000


PART I. REGISTRANT INFORMATION

Full name of Registrant: BIOINCUBATION, INC.

Address of Registrant:  625 N. Michigan Avenue
                        Chicago, Illinois 60611


PART II.  RULE 12b-25 (b) and (c)

If the subject report could not be filed without unreasonable
effort or expense, and the registrant seeks relief pursuant to
Rule 12b-25(b), the following should be completed. (Check box if
appropriate).

              (a) The reasons described in reasonable detail in
                  Part III of this form could not be eliminated
                  without unreasonable effort or expense;

   [x]        (b) The subject annual report on Form 10-Q will be
                  filed on or before the 5th calendar day
                  following the prescribed due date; and

              (c) The accountant's statement or other exhibit
                  required by Rule 12b-25(c) has been attached if
                  applicable.


PART III.  NARRATIVE

State below in reasonable detail the reasons why Form 10-K could
not be filed within the prescribed time period:

    The Registrant during this year merged with another entity
and therefore the Registrant requires additional time to compile
the necessary information to prepare and file the Form 10-K.  The
Company is working with its attorneys as expeditiously as
possible to do so.  The Registrant is also working with its
independent accountants to compile the necessary financial data
to prepare audited financials for the Company which shall be
incorporated into the Form 10-Q.


PART IV.   OTHER INFORMATION

(1)     Name and telephone number of person to contact in regard
        to this notification:

        Peter Moulinos, Esq.        (212)           265-4600
        (Name)                   (Area Code)   (Telephone number)

(2)     Have all other periodic reports required under Section 13
        or 15(d) of the Securities Exchange Act of 1934 during
        the preceding 12 months or for such shorter period that
        the registrant was required to file such report(s) been
        filed?  If the answer is no, identify report(s).

                                      [x] Yes       [ ] No

(3)     Is it anticipated that any significant change in results
        of operations from the corresponding period for the last
        fiscal year will be reflected by the earnings statements
        to be included in the subject report or portion thereof?

                                      [ ] Yes       [x] No

        If so: attach an explanation of the anticipated change,
        both narratively and quantitatively, and, if appropriate,
        state the reasons why a reasonable estimate of the
        results cannot be made.


The Company has caused this notification to be signed on its
behalf by the undersigned thereunto duly authorized.

Date: May 15, 2000

    BIOINCUBATION, INC.
    --------------------
By: /s/ Julian Andrews
    President



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission